Publication:
GLIOBLASTOMA IN ELDERLY PATIENTS: HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN A RANDOMIZED TRIAL COMPARING 6-WEEKS OF TADIOTHERAPY (RT) VS HYPOFRACTIONATED RT OVER 2 WEEKS VS TEMOZOLOMIDE CHEMOTHERAPY (TMZ)

Simple item page
dc.contributor.authorsMalmstrom, A.; Gronberg, B.; Stupp, R.; Marosi, C.; Frappaz, D.; Schultz, H.; Abacioglu, U.; Henriksson, R.
dc.date.accessioned2022-03-12T16:13:36Z
dc.date.accessioned2026-01-11T10:48:28Z
dc.date.available2022-03-12T16:13:36Z
dc.date.issued2010
dc.identifier.doidoiWOS:000281184800067
dc.identifier.issn1522-8517
dc.identifier.urihttps://hdl.handle.net/11424/224958
dc.identifier.wosWOS:000281184800067
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS INC
dc.relation.ispartofNEURO-ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleGLIOBLASTOMA IN ELDERLY PATIENTS: HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN A RANDOMIZED TRIAL COMPARING 6-WEEKS OF TADIOTHERAPY (RT) VS HYPOFRACTIONATED RT OVER 2 WEEKS VS TEMOZOLOMIDE CHEMOTHERAPY (TMZ)
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage19
oaire.citation.startPage18
oaire.citation.titleNEURO-ONCOLOGY
oaire.citation.volume12

Files

Collections

Araştırma Çıktıları